Numab

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases such as chronic inflammation and cancer. It features a plug-and-play platform that substantially reduces the random nature of the discovery process to predictably yield ready-to-develop multispecific biotherapeutics.

Domain

numab.com

Industry

Biopharma

Employees

51-100

Last Funding

$54.8M

Founded

2010

Frequently Asked Questions

What technologies does Numab use?+

Numab uses 15 technologies including AOS, Constant Contact, Google Analytics.

What industry is Numab in?+

Numab operates in the Biopharma industry.

Where is Numab based?+

Numab is headquartered in Switzerland.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026